IP Library › Granted Patent US 12,746,119
Granted Patent B2
US 12,746,119 · App. 19/329,873 · Granted Sep 29, 2026

Transcatheter heart valve prosthesis assembled inside heart chambers or blood vessels

Inventors: Ramji Iyer (Plymouth, MN); Stephen Anderson (Minneapolis, MN); Samuel Thomas Johnson (Maple Grove, MN)
Assignee: Laplace Interventional Inc.
A61F2/2418A61F2/2436
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,746,119
App. No.
19/329,873
Granted
Sep 29, 2026
Kind
B2
Abstract

Some embodiments described herein include a heart valve replacement system that may be delivered to the targeted heart valve site via a delivery catheter. In some embodiments, the heart valve replacement system can assemble a valve device after the valve device is delivered to the heart. In some embodiments, heart valve replacement system includes two anterior flaps that are separate but overlap each other.

Claims (38)

1 . A method for deploying a prosthetic heart valve at a native heart valve site, the method comprising:

attaching the prosthetic heart valve to one or more delivery catheters using removable sutures, wherein the prosthetic heart valve comprises:

an occluder frame;

an occluder disposed in the occluder frame and comprising valve leaflets; and

one or more anchoring flaps extending from the occluder frame,

wherein the occluder frame and the one or more anchoring flaps are: (i) collapsible to a low-profile delivery configuration and (ii) expandable to a deployed configuration;

navigating, using the one or more delivery catheters, the prosthetic heart valve in the low-profiled delivery configuration to the native heart valve site;

at the native heart valve site, causing the prosthetic heart valve to emerge from a sheath catheter while holding the removable sutures in tension to thereby maintain the occluder frame and the one or more anchoring flaps in the low-profile delivery configuration after the emergence of the prosthetic heart valve from the sheath catheter;

after the emergence of the prosthetic heart valve from the sheath catheter, slacking tension of at least a first one of the removable sutures to allow the one or more anchoring flaps to expand to a deployed natural shape that extends radially away from the occluder frame and into contact with ventricular wall anatomical areas near the native heart valve site;

controllably expanding the occluder frame into contract with an annulus of the native heart valve site by slacking tension of at least a second one of the removable sutures; and

after controllably expanding the occluder frame, detaching the prosthetic heart valve from the one or more delivery catheters by releasing the removable sutures from the prosthetic heart valve.

2 . The method of claim 1 , wherein the one or more anchoring flaps comprise a posterior anchoring flap and one or more anterior anchoring flaps.

3 . The method of claim 2 , wherein the one or more anterior anchoring flaps are controllably deployed to extend into a right ventricular outflow tract (RVOT).

4 . The method of claim 3 , wherein the one or more anterior anchoring flaps comprise two anterior anchoring flaps.

5 . The method of claim 2 , wherein the posterior anchoring flap is controllably deployed into contact with the ventricular wall below the native heart valve site.

6 . The method of claim 2 , wherein the posterior flap extends from the occluder frame directionally opposite of the one or more anterior anchoring flaps.

7 . The method of claim 2 , wherein the one or more anterior anchoring flaps and/or the posterior anchoring flap occlude a portion of an opening defined by the annulus of the native heart valve site.

8 . The method of claim 1 , wherein the occluder frame and the anchoring flaps are self-expandable.

9 . The method of claim 1 , wherein the prosthetic heart valve is navigated, using the one or more delivery catheters, to the native heart valve site via a transjugular access route.

10 . The method of claim 1 , wherein the prosthetic heart valve is navigated, using the one or more delivery catheters, to the native heart valve site via a transfemoral access route.

11 . The method of claim 1 , wherein, when the prosthetic heart valve is implanted at the native heart valve site, an inlet end portion of the prosthetic heart valve is positioned in an atrium and an outlet end portion of the prosthetic heart valve is positioned in a ventricle.

12 . A method for deploying a prosthetic heart valve at a native tricuspid heart valve site, the method comprising:

navigating, using one or more delivery catheters, the prosthetic heart valve in a low-profile delivery configuration to the native tricuspid heart valve site, wherein the prosthetic heart valve is attached to the one or more delivery catheters, and held in the low-profile delivery configuration, by removable sutures, wherein the prosthetic heart valve comprises:

an occluder frame;

an occluder disposed in the occluder frame and comprising valve leaflets; and

anchoring flaps extending from the occluder frame,

wherein the occluder frame and the anchoring flaps are collapsible to the low-profile delivery configuration and self-expandable to a deployed configuration;

at the native tricuspid heart valve site, slacking tension of at least a first one of the removable sutures to allow a first anchoring flap of the anchoring flaps to expand to a deployed natural shape that extends radially away from the occluder frame and into contact with first right ventricle wall areas near the native tricuspid heart valve site;

after controllably deploying the first anchoring flap, controllably deploying a second anchoring flap of the anchoring flaps from attachment to the one or more delivery catheters, wherein the second anchoring flap is controllably deployed into contact with second right ventricle wall areas near the native tricuspid heart valve site; and

controllably expanding the occluder frame within an annulus of the native tricuspid heart valve site by slacking tension of at least a second one of the removable sutures.

13 . The method of claim 12 , wherein the anchoring flaps comprise a posterior anchoring flap and one or more anterior anchoring flaps.

14 . The method of claim 13 , wherein the one or more anterior anchoring flaps comprise two anterior anchoring flaps.

15 . The method of claim 14 , wherein the two anterior anchoring flaps are controllably deployed to extend into a right ventricular outflow tract (RVOT).

16 . The method of claim 13 , wherein the posterior anchoring flap is controllably deployed into contact with the first right ventricle wall.

17 . The method of claim 13 , wherein the posterior flap extends from the occluder frame directionally opposite of the one or more anterior anchoring flaps.

18 . The method of claim 13 , wherein the one or more anterior anchoring flaps and/or the posterior anchoring flap occlude a portion of an opening defined by the annulus of the native tricuspid heart valve site.

19 . The method of claim 12 , wherein, wherein the prosthetic tricuspid heart valve is navigated, using the one or more delivery catheters, to the native heart valve site via a transjugular access route.

20 . The method of claim 12 , wherein, wherein the prosthetic tricuspid heart valve is navigated, using the one or more delivery catheters, to the native heart valve site via a transfemoral access route.

Assignments (7)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 22, 2025
From: IYER, RAMJI
To: LAPLACE INTERVENTIONAL INC.
Reel/Frame 072633/0500 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 22, 2025
From: JOHNSON, SAMUEL THOMAS
To: NPX MEDICAL, LLC
Reel/Frame 072633/0599 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 22, 2025
From: ANDERSON, STEPHEN
To: HAARSTAD ENGINEERING SERVICE
Reel/Frame 072633/0665 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 22, 2025
From: NPX MEDICAL, LLC
To: LAPLACE INTERVENTIONAL INC.
Reel/Frame 072633/0744 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 22, 2025
From: HAARSTAD ENGINEERING SERVICE
To: LAPLACE INTERVENTIONAL INC.
Reel/Frame 072633/0769 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 22, 2025
From: IYER, RAMJI
To: LAPLACE INTERVENTIONAL LLC
Reel/Frame 072633/0893 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 22, 2025
From: LAPLACE INTERVENTIONAL LLC
To: LAPLACE INTERVENTIONAL INC.
Reel/Frame 072633/0930 →
Continuity (8)
Continuation 19184065 · Apr 21, 2025
Continuation 18201900 · May 25, 2023
Continuation 17747523 · May 18, 2022
Continuation 17465172 · Sep 2, 2021
Continuation 17165244 · Feb 2, 2021
Provisional Application 63130201 · Dec 23, 2020
Provisional Application 62970967 · Feb 6, 2020
Related Publication 20260000509A1 · Jan 1, 2026
References Cited (113)
US 5824069A · Lemole · 1998 [cited by applicant]
US 6312464B1 · Navia · 2001 [cited by applicant]
US 6458153B1 · Bailey et al. · 2002 [cited by applicant]
US 7763062B2 · Spiridigliozzi · 2010 [cited by examiner]
US 8728155B2 · Montorfano et al. · 2014 [cited by applicant]
US 9393110B2 · Levi et al. · 2016 [cited by applicant]
US 9579196B2 · Morriss · 2017 [cited by applicant]
US 9681951B2 · Ratz et al. · 2017 [cited by applicant]
US 10213307B2 · Dwork · 2019 [cited by applicant]
US 10321995B1 · Christianson · 2019 [cited by applicant]
US 10500038B1 · Orlov · 2019 [cited by examiner]
US 10507097B2 · Cartledge · 2019 [cited by examiner]
US 10583000B2 · Ratz · 2020 [cited by applicant]
US 10595994B1 · Christianson · 2020 [cited by applicant]
US 10653522B1 · Vidlund et al. · 2020 [cited by applicant]
US 10779936B2 · Pollak · 2020 [cited by applicant]
US 10813779B2 · Fleming, III et al. · 2020 [cited by applicant]
US 11234813B2 · Perrin · 2022 [cited by applicant]
US 11253359B2 · Vidlund · 2022 [cited by applicant]
US 11510777B1 · Iyer et al. · 2022 [cited by applicant]
US 11638643B1 · Askegaard · 2023 [cited by examiner]
US 12376963B1 · Anderson · 2025 [cited by examiner]
US 12440333B1 · Schneider · 2025 [cited by examiner]
US 20050149181A1 · Eberhardt · 2005 [cited by applicant]
US 20070055356A1 · Eidenschink · 2007 [cited by applicant]
US 20080065204A1 · Macoviak et al. · 2008 [cited by applicant]
US 20090281618A1 · Hill · 2009 [cited by applicant]
US 20100023046A1 · Heidner et al. · 2010 [cited by applicant]
US 20100036479A1 · Hill · 2010 [cited by applicant]
US 20100161045A1 · Righini · 2010 [cited by applicant]
US 20100217382A1 · Chau et al. · 2010 [cited by applicant]
US 20100316830A1 · Hartley et al. · 2010 [cited by applicant]
US 20110137397A1 · Chau et al. · 2011 [cited by applicant]
US 20110319989A1 · Lane et al. · 2011 [cited by applicant]
US 20120083832A1 · Delaloye et al. · 2012 [cited by applicant]
US 20130190861A1 · Chau et al. · 2013 [cited by applicant]
US 20130211508A1 · Lane et al. · 2013 [cited by applicant]
US 20130325110A1 · Khalil et al. · 2013 [cited by applicant]
US 20130338787A1 · Hopkins · 2013 [cited by examiner]
US 20140135910A1 · Hauser · 2014 [cited by applicant]
US 20140207231A1 · Hacohen et al. · 2014 [cited by applicant]
US 20140222142A1 · Kovalsky et al. · 2014 [cited by applicant]
US 20140257467A1 · Lane et al. · 2014 [cited by applicant]
US 20140277390A1 · Ratz · 2014 [cited by applicant]
US 20140296969A1 · Tegels et al. · 2014 [cited by applicant]
US 20140296975A1 · Tegels et al. · 2014 [cited by applicant]
US 20140324164A1 · Gross · 2014 [cited by examiner]
US 20140350669A1 · Gillespie et al. · 2014 [cited by applicant]
US 20150073544A1 · Gorman, III · 2015 [cited by applicant]
US 20150119981A1 · Khairkhahan et al. · 2015 [cited by applicant]
US 20150196390A1 · Ma et al. · 2015 [cited by applicant]
US 20150216653A1 · Freudenthal · 2015 [cited by applicant]
US 20150327994A1 · Morriss et al. · 2015 [cited by applicant]
US 20160158003A1 · Wallace et al. · 2016 [cited by applicant]
US 20160262887A1 · Chang et al. · 2016 [cited by applicant]
US 20160278922A1 · Braido et al. · 2016 [cited by applicant]
US 20170056166A1 · Ratz et al. · 2017 [cited by applicant]
US 20170071733A1 · Ghione et al. · 2017 [cited by applicant]
US 20170128199A1 · Gurovich et al. · 2017 [cited by applicant]
US 20170128208A1 · Christianson et al. · 2017 [cited by applicant]
US 20170128209A1 · Morriss et al. · 2017 [cited by applicant]
US 20170216023A1 · Lane et al. · 2017 [cited by applicant]
US 20170216026A1 · Quill et al. · 2017 [cited by applicant]
US 20170325945A1 · Dale et al. · 2017 [cited by applicant]
US 20180000586A1 · Ganesan · 2018 [cited by applicant]
US 20180318071A1 · Lozonschi · 2018 [cited by applicant]
US 20180368977A1 · Gorman et al. · 2018 [cited by applicant]
US 20190008635A1 · Francis et al. · 2019 [cited by applicant]
US 20190008636A1 · Francis et al. · 2019 [cited by applicant]
US 20190029811A1 · Bishop et al. · 2019 [cited by applicant]
US 20190282363A1 · Barajas-Torres · 2019 [cited by examiner]
US 20190365549A1 · Folan · 2019 [cited by examiner]
US 20200000590A1 · Salahieh · 2020 [cited by examiner]
US 20200121452A1 · Saikrishnan et al. · 2020 [cited by applicant]
US 20200179109A1 · Reimer · 2020 [cited by applicant]
US 20200188097A1 · Perrin · 2020 [cited by examiner]
US 20200237506A1 · Christianson et al. · 2020 [cited by applicant]
US 20200268512A1 · Mohl · 2020 [cited by applicant]
US 20210154011A1 · Christianson et al. · 2021 [cited by applicant]
US 20210186693A1 · Vidlund · 2021 [cited by applicant]
US 20210220126A1 · Perrin · 2021 [cited by applicant]
US 20210220127A1 · Vidlund et al. · 2021 [cited by applicant]
US 20210236280A1 · Christianson et al. · 2021 [cited by applicant]
US 20210259830A1 · Enriquez-Sarano · 2021 [cited by applicant]
US 20210275300A1 · Walsh · 2021 [cited by examiner]
US 20210315694A1 · Vidlund · 2021 [cited by applicant]
US 20210330459A1 · Christianson · 2021 [cited by applicant]
US 20210346153A1 · Vietmeier et al. · 2021 [cited by applicant]
US 20210369454A1 · Stack et al. · 2021 [cited by applicant]
US 20210401572A1 · Nasr et al. · 2021 [cited by applicant]
US 20220160499A1 · Miyashiro et al. · 2022 [cited by applicant]
US 20220331103A1 · Von Oepen · 2022 [cited by examiner]
US 20220409369A1 · Christianson et al. · 2022 [cited by applicant]
US 20230016821A1 · Dang · 2023 [cited by examiner]
US 20240374380A1 · Sands · 2024 [cited by examiner]
US 20250268737A1 · Nolan · 2025 [cited by examiner]
CN 109843220A · 2019 [cited by examiner]
CN 118845303A · 2024 [cited by examiner]
CN 120053149A · 2025 [cited by examiner]
CN 111902103B · 2025 [cited by examiner]
EP 2938291B1 · 2019 [cited by examiner]
EP 3520736A1 · 2019 [cited by applicant]
WO WO2009094500 · 2009 [cited by applicant]
WO WO2015052570 · 2015 [cited by applicant]
WO WO2022174057A1 · 2022 [cited by examiner]
WO WO2023091769A1 · 2023 [cited by examiner]
WO WO2024145164A1 · 2024 [cited by examiner]
WO WO2024161287A1 · 2024 [cited by examiner]
WO WO2025129111A1 · 2025 [cited by examiner]
WO WO2025207672A1 · 2025 [cited by examiner]
Extended European Search Report in European Appln No. 21750572.6, dated May 23, 2023, 10 pages. [cited by applicant]
Invitation to Pay Additional Fees in International Application No. PCT/US2021/016150, dated Apr. 6, 2021, 2 pages. [cited by applicant]
PCT International Search Report and Written Opinion in International Appln. No. PCT/US2021/016150, dated Jun. 29, 2021, 17 pages. [cited by applicant]